348 related articles for article (PubMed ID: 31299111)
1. Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells.
Ogasawara H; Furuno M; Edamura K; Noguchi M
J Leukoc Biol; 2019 Nov; 106(5):1069-1077. PubMed ID: 31299111
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.
Wang J; Zhang Y; Li C; Ding Y; Hu S; An H
Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
4. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
[TBL] [Abstract][Full Text] [Related]
5. Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.
Subramanian H; Gupta K; Ali H
J Allergy Clin Immunol; 2016 Sep; 138(3):700-710. PubMed ID: 27448446
[TBL] [Abstract][Full Text] [Related]
6. Endogenous protein and enzyme fragments induce immunoglobulin E-independent activation of mast cells via a G protein-coupled receptor, MRGPRX2.
Tatemoto K; Nozaki Y; Tsuda R; Kaneko S; Tomura K; Furuno M; Ogasawara H; Edamura K; Takagi H; Iwamura H; Noguchi M; Naito T
Scand J Immunol; 2018 May; 87(5):e12655. PubMed ID: 29484687
[TBL] [Abstract][Full Text] [Related]
7. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
8. Anti-pseudo-allergy effect of isoliquiritigenin is MRGPRX2-dependent.
Hou Y; Che D; Ma P; Zhao T; Zeng Y; Wang N
Immunol Lett; 2018 Jun; 198():52-59. PubMed ID: 29684393
[TBL] [Abstract][Full Text] [Related]
9. Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant.
Alkanfari I; Gupta K; Jahan T; Ali H
J Immunol; 2018 Jul; 201(2):343-349. PubMed ID: 29794017
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.
Ogasawara H; Noguchi M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831128
[TBL] [Abstract][Full Text] [Related]
11. Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses.
Callahan BN; Kammala AK; Syed M; Yang C; Occhiuto CJ; Nellutla R; Chumanevich AP; Oskeritzian CA; Das R; Subramanian H
Front Immunol; 2020; 11():703. PubMed ID: 32391014
[TBL] [Abstract][Full Text] [Related]
12. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
McNeil BD; Pundir P; Meeker S; Han L; Undem BJ; Kulka M; Dong X
Nature; 2015 Mar; 519(7542):237-41. PubMed ID: 25517090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
[TBL] [Abstract][Full Text] [Related]
14. Store-Operated Calcium Entry via STIM1 Contributes to MRGPRX2 Induced Mast Cell Functions.
Occhiuto CJ; Kammala AK; Yang C; Nellutla R; Garcia M; Gomez G; Subramanian H
Front Immunol; 2019; 10():3143. PubMed ID: 32038646
[TBL] [Abstract][Full Text] [Related]
15. MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions.
Zhang F; Hong F; Wang L; Fu R; Qi J; Yu B
Int Immunopharmacol; 2022 Jan; 102():108389. PubMed ID: 34920312
[TBL] [Abstract][Full Text] [Related]
16. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.
Wolf K; Kühn H; Boehm F; Gebhardt L; Glaudo M; Agelopoulos K; Ständer S; Ectors P; Zahn D; Riedel YK; Thimm D; Müller CE; Kretschmann S; Kremer AN; Chien D; Limjunyawong N; Peng Q; Dong X; Kolkhir P; Scheffel J; Søgaard ML; Weigmann B; Neurath MF; Hawro T; Metz M; Fischer MJM; Kremer AE
J Allergy Clin Immunol; 2021 Aug; 148(2):506-522.e8. PubMed ID: 33617860
[TBL] [Abstract][Full Text] [Related]
17. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
[TBL] [Abstract][Full Text] [Related]
18. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
19. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2.
Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L
Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
